PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $478.51 | -1.9% | -10.4% | -15.4% | -17.8% | +9.5% | +239.7% | +492.3% | |
| TTM Revenue | $1.28B | +13.4% | – | +13.4% | – | +149.0% | +100.0% | +100.0% | |
| TTM EPS | -$12.88 | -0.7% | – | -0.7% | – | -0.3% | +30.9% | +11.8% | |
| 21.11 | -1.9% | -10.4% | -15.2% | -4.3% | +33.2% | -82.0% | +264.0% | ||
| 8.61 | -1.9% | -10.4% | -15.2% | -38.0% | -35.7% | – | – | ||
| $10.56B | -2.0% | -10.8% | -15.8% | -16.6% | +15.4% | +324.3% | +893.0% | ||
| -32.90 | +2.0% | +10.9% | +15.8% | +22.4% | -10.0% | -360.1% | -632.7% | ||
| Market Cap | $11B | -1.9% | -10.4% | -15.2% | -16.9% | +11.4% | +324.3% | +711.6% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 3.62 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 0.92 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 2.17 | - |
Formula
Data Sources & References
- MDGL Official Website www.madrigalpharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1157601/000162828026009514/0001628280-26-009514-index.htm
- MDGL Profile on Yahoo Finance finance.yahoo.com/quote/MDGL
- MDGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdgl
